Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The High-affinity laminin receptor, also known as 40S ribosomal protein SA (RPSA) or the 37/67 kDa laminin receptor (37/67LR), is a multifunctional protein that serves as both a component of the 40S ribosomal subunit and a non-integrin cell surface receptor (UniProt P08865). On the plasma membrane, it facilitates high-affinity binding to laminin-1, a major component of the basement membrane, thereby regulating cell adhesion, migration, and signaling (PMID: 23536039). RPSA is frequently overexpressed in various malignant tumors, including breast, lung, and colorectal cancers, where its expression levels correlate with increased metastatic potential and poor clinical prognosis (PMID: 23536039, PMID: 21114738). Beyond its role in oncology, RPSA acts as a receptor for several human pathogens, including the cellular prion protein (PrPc), various viruses such as Dengue and Adeno-associated virus (AAV), and certain bacteria (PMID: 15107831). The protein's dual localization—cytoplasmic for translation and membrane-bound for extracellular interaction—makes it a unique but challenging therapeutic target. Therapeutic strategies targeting RPSA include the use of small molecules like epigallocatechin gallate (EGCG), which binds the receptor with high affinity, as well as monoclonal antibodies and siRNA to inhibit its pro-metastatic and pathogen-mediating functions (PMID: 21114738, PMID: 15107831). Current research also explores its role in neurodegenerative conditions like Alzheimer's disease, where it may interact with amyloid-beta peptides (PMID: 23536039).
Competitive inhibition of laminin-1 binding to the extracellular domain, downregulation of surface receptor expression, and blockade of pathogen internalization pathways.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 40S ribosomal protein SA (High-affinity laminin receptor) (RPSA).